NO20006243L - Beskyttelse av neuroner fra ischemi - Google Patents

Beskyttelse av neuroner fra ischemi

Info

Publication number
NO20006243L
NO20006243L NO20006243A NO20006243A NO20006243L NO 20006243 L NO20006243 L NO 20006243L NO 20006243 A NO20006243 A NO 20006243A NO 20006243 A NO20006243 A NO 20006243A NO 20006243 L NO20006243 L NO 20006243L
Authority
NO
Norway
Prior art keywords
neurons
ischemia
protection
bilobalide
stimulation
Prior art date
Application number
NO20006243A
Other languages
English (en)
Other versions
NO20006243D0 (no
Inventor
Krish Chandrasekaran
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20006243D0 publication Critical patent/NO20006243D0/no
Publication of NO20006243L publication Critical patent/NO20006243L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Anvendelsen av et ekstrakt av ginkgo biloba omfattende bilobalid for å beskytte neuroner mot iskemisk skade assosiert med stimulering av mitokondriell genekspresjon, beskrives.
NO20006243A 1998-06-11 2000-12-08 Beskyttelse av neuroner fra ischemi NO20006243L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8912698P 1998-06-11 1998-06-11
US9686998A 1998-06-11 1998-06-11
PCT/EP1999/004098 WO1999064028A1 (en) 1998-06-11 1999-06-10 Protecting neurons from ischemia

Publications (2)

Publication Number Publication Date
NO20006243D0 NO20006243D0 (no) 2000-12-08
NO20006243L true NO20006243L (no) 2001-02-08

Family

ID=26780277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006243A NO20006243L (no) 1998-06-11 2000-12-08 Beskyttelse av neuroner fra ischemi

Country Status (8)

Country Link
EP (1) EP1085886A1 (no)
JP (1) JP2002517456A (no)
KR (1) KR20010078734A (no)
AU (1) AU4772099A (no)
CA (1) CA2331918A1 (no)
IL (1) IL140196A0 (no)
NO (1) NO20006243L (no)
WO (1) WO1999064028A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US7585523B2 (en) * 2002-08-27 2009-09-08 Targeted Medical Pharma Composition and method to augment and sustain neurotransmitter production
KR100623164B1 (ko) * 2004-07-22 2006-09-19 재단법인서울대학교산학협력재단 뇌신경 보호효과를 갖는 신규한 은행잎 엑스를 정제하는방법 및 이를 함유하는 조성물
KR100723609B1 (ko) * 2006-04-28 2007-06-04 주식회사 유유 신규한 조성의 알츠하이머형 치매 및 파킨슨씨병 예방 또는 치료용 은행잎 추출물, 그리고 은행잎으로부터의 추출 및 정제 방법
FR2904222A1 (fr) * 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
BRPI0715633A2 (pt) * 2006-08-23 2013-07-02 Univ Montana mÉtodo de reduÇço de dano em cÉlula neuronal
WO2012047063A2 (ko) * 2010-10-08 2012-04-12 제일약품주식회사 당귀 추출물, 은행엽 추출물 단독； 또는 당귀 추출물 및 은행엽 추출물의 혼합물을 포함하는 치매 치료보조용 또는 치매치료용 약학적 조성물
CN105125897A (zh) * 2015-10-05 2015-12-09 南京多宝生物科技有限公司 一种含天麻的植物组合物提取方法和应用
CN110893183A (zh) * 2018-09-13 2020-03-20 成都百裕制药股份有限公司 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3338995A1 (de) * 1983-10-27 1985-05-09 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe Bilobalid enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono

Also Published As

Publication number Publication date
JP2002517456A (ja) 2002-06-18
AU4772099A (en) 1999-12-30
CA2331918A1 (en) 1999-12-16
KR20010078734A (ko) 2001-08-21
WO1999064028A1 (en) 1999-12-16
NO20006243D0 (no) 2000-12-08
IL140196A0 (en) 2002-02-10
EP1085886A1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
ATE304840T1 (de) Hautpflegezusammensetzung
IT7829949A0 (it) Dispositivo per serratura per evitare l'accesso non autorizzato.
WO2002022611A3 (en) Caspase inhibitors and uses thereof
DE60022758D1 (de) Hautpflegezusammensetzung
DE50104383D1 (de) Benzofuranonderivate enthaltende formulierung zum schutz vor oxidativem stress
NO20006243L (no) Beskyttelse av neuroner fra ischemi
RU94044453A (ru) Применение 2-фенил-3-ароилбензотиофенов для ингибирования себореи и угрей
DK0693278T3 (da) Kombinationer af vasoaktive stoffer med fedtsyrer for at forebygge tab af hår
EP0663935A4 (en) AQUEOUS COMPOSITION OF NITROCELLULOSE.
IE43618L (en) Benzimidazole derivatives
EP0438856A3 (en) Use of melatonin to protect the skin against the influence of uv-rays
BE883068A (fr) Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives
DE3687283D1 (de) Mittel zum schutz des gehirns.
MX9204175A (es) Composicion para proteger el maiz contra daño ocasionado por la interaccion de un insecticida-nematicida de organofosfato.
TR200101109T2 (tr) Geliştirilmiş damar daraltan tesirliliğe sahip bulunan flutikazon losyonu
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
DK1240254T3 (da) Sikkerhedsteknisk forbedrede pigmenttilberedninger
AT3862U3 (de) Zerkleinerungsvorrichtung nach dem prinzip der rotorzerkleinerung
ES456280A1 (es) Un procedimiento para la obtencion de alfa-2,5,9-trimetil- benzo(b)tieno(2,3-f)morfano.
ATE327727T1 (de) Hautpflegemittel
DE3878087D1 (de) 2-hydroxybenzophenon-hydrazide und derivate davon.
ATE118781T1 (de) Sterinverbindung.
KR890700028A (ko) 약제학적 활성화합물 및 이의 혼합물, 유기조성물 및 금속염
SU628921A1 (ru) Вещество, обладающее антикурарным действием дл использовани в экспиременте
KR960021043A (ko) 스코폴레틴을 포함하는 b형 간염 치료제

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application